Claims for Patent: 7,019,195

Summary for Patent: 7,019,195

Title:	Method for conferring resistance or tolerance aganist furovirus, potyvirus, tospovirus, and cucomovirus to plant cells
Abstract:	The present invention relates to a method to confer resistance or tolerance to more than one virus from the group consisting of furovirus, potyvirus, tospovirus, and cucomovirus, using sense and antisense RNA fragments of a sequence from their genomes. The sense and antisense RNA fragments are capable of pairing and forming a double-stranded RNA molecule, thereby reducing expression of the viral genome.
Inventor(s):	Heifetz; Peter Bernard (Durham, NC), Patton; David Andrew (Durham, NC), Levin; Joshua Zvi (Durham, NC), Que; Qiudeng (Apex, NC), De Haan; Petrus Theodorus (Enkhuizen, NL), Gielen; Johannes Jacobus Ludgerus (Aucamville, FR)
Assignee:	Syngenta Participations AG (Basel, CH)
Application Number:	09/309,038
Patent Claims:	1. A method for conferring resistance or tolerance to more than one virus selected from the group consisting of a furovirus, potyvirus, tospovirus, and cucomovirus upon a plant cell comprising the step of: introducing into a plant cell more than one pair of DNA sequences wherein for each pair, the first DNA sequence encodes a portion of the viral genome of a furovirus, potyvirus, tospovirus, or cucomovirus, and the second DNA sequence of the pair encodes a sequence that is antisense to the first DNA sequence, such that the RNA sequences encoded by the first and second DNA sequences of a pair form a double-stranded RNA molecule when expressed in said plant cell, resulting upon viral infection, in reduced expression of the portion of the viral genome from which the DNA sequences of that pair were derived, and wherein at least two of the introduced pairs of DNA sequences were derived from different viruses of said group, resulting in resistance or tolerance of said plant cell to more than one virus of said group. 2. The method of claim 1, wherein the first DNA sequence of a pair comprises a nucleotide sequence obtained from a viral coat protein gene, a viral nucleocapsid protein gene, a viral replicase gene, a movement protein gene or portions thereof. 3. The method of claim 1, wherein said first DNA sequence and said second DNA sequence of each pair are stably integrated in the genome of said cell. 4. The method of claim 1, wherein said first DNA sequence and said second DNA sequence of each pair are comprised in two different DNA molecules. 5. The method of claim 4, wherein said DNA sequences further comprise a first promoter operably linked to said first DNA sequence and a second promoter operably linked to said second DNA sequence of each pair. 6. The method of claim 1, wherein said first DNA sequence and said second DNA sequence of a pair are comprised in one DNA molecule. 7. The method of claim 6, wherein said first DNA sequence and said second DNA sequence of a pair are comprised in the same DNA strand of said DNA molecule. 8. The method of claim 7, wherein said RNA sequences encoded by said first and second DNA sequences of a pair are comprised in one RNA molecule. 9. The method of claim 8, wherein said RNA molecule is capable of folding such that said RNA sequences comprised therein form a double-stranded region. 10. The method of claim 8, wherein said DNA molecule further comprises a promoter operably linked to said first and said second DNA sequence. 11. The method of claim 10, wherein said promoter is a heterologous promoter. 12. The method of claim 10, wherein said promoter is a tissue-specific promoter. 13. The method of claim 10, wherein said promoter is a developmentally regulated promoter. 14. The method of claim 10, wherein said promoter is a constitutive promoter. 15. The method of claim 10, wherein said promoter is an inducible promoter. 16. The method of claim 8, wherein said DNA molecule further comprises a linker between the first and second DNA sequences. 17. The method of claim 16, wherein the linker comprises intron processing signals. 18. The method of claim 7, wherein said RNA sequences encoded by the first and second DNA sequences are comprised in two RNA molecules. 19. The method of claim 18, wherein said first DNA sequence is operably linked to a first promoter and said second DNA sequence is operably linked to a second promoter. 20. The method of claim 18, wherein said first DNA sequence and said second DNA sequence are operably linked to a bidirectional promoter. 21. The method of claim 7, wherein said first DNA sequence and said second DNA sequence are comprised in complementary strands of said DNA molecule. 22. The method of claim 21, wherein said first DNA sequence is the complementary DNA strand of said second DNA sequence in said DNA molecule. 23. The method of claim 22, wherein said DNA molecule further comprises a first promoter operably linked to said first DNA sequence. 24. A plant cell obtained by the method of claim 1, wherein said cell is resistant or tolerant to more than one virus selected from the group consisting of said furovirus, potyvirus, topsovirus and cucomovirus. 25. A plant comprising the plant cell of claim 24, wherein the plant is virus resistant or tolerant to more than one virus selected from the group consisting of said furovirus, potyvirus, tospovirus and cucomovirus. 26. A plant regenerated from the plant cell of claim 24, wherein the plant is resistant or tolerant to more than one virus selected from the group consisting of said furovirus, potyvirus, tospovirus and cucomovirus. 27. Seeds produced from the plant of claim 26, wherein said seeds are resistant or tolerant to more than one virus selected from the group consisting of said furovirus, potyvirus, tospovirus and cucomovirus and comprise said more than one pair of DNA sequences. 28. The method of claim 1, wherein one of said pairs of DNA sequences comprises a nucleotide sequence obtained from a furovirus replicase gene or portion thereof. 29. The method of claim 1, wherein one of said pairs of DNA sequences comprises a nucleotide sequence obtained from the beet necrotic yellow vein virus (BNYVV). 30. The method of claim 29, wherein said pair DNA sequences comprises a nucleotide sequence obtained from the replicase gene (RNA1) of the beet necrotic yellow vein virus or portion thereof. 31. The method of claim 30, wherein the portion of the replicase gene from BNYVV comprises the 3' end. 32. The method of claim 1, wherein one of said pairs of DNA sequences comprises a nucleotide sequence obtained from a potyvirus. 33. The method of claim 1, wherein one of said pairs of DNA sequences comprises a nucleotide sequence obtained from a tospovirus. 34. The method of claim 1, wherein one of said pairs of DNA sequences comprises a nucleotide sequence obtained from a cucomovirus. 35. Progeny obtained from the plant of claim 26, wherein said progeny are resistant or tolerant to more than one virus selected from the group consisting of said furovirus, potyvirus, tospovirus and cucomovirus, and wherein said progeny comprise said more than one pair of DNA sequences.

Details for Patent 7,019,195

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2018-05-26
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2018-05-26
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2018-05-26